Sulforhodamine B colorimetric assay for cytotoxicity screening. (Q51032435)

27 March 2018

title

Sulforhodamine B colorimetric assay for cytotoxicity screening. (English)

1 reference

27 March 2018

0 references

Vanicha Vichai

1

1 reference

27 March 2018

Kanyawim Kirtikara

series ordinal

2

1 reference

27 March 2018

publication date

1 January 2006

1 reference

27 March 2018

published in

Nature Protocols

1 reference

27 March 2018

volume

1

1 reference

27 March 2018

issue

3

1 reference

27 March 2018

page(s)

1112-1116

1 reference

27 March 2018

https://scigraph.springernature.com/pub.10.1038/nprot.2006.179

exact match

0 references

cites work

New colorimetric cytotoxicity assay for anticancer-drug screening

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.179

A rapid fluorometric DNA assay for the measurement of cell density and proliferation in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.179

Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.179

A colorimetric assay for the measurement of the sensitivity of herpes simplex viruses to antiviral agents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.179

A generally applicable, high-throughput screening-compatible assay to identify, evaluate, and optimize antimicrobial agents for drug therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.179

An anti-herpes simplex virus-type 1 agent from Xylaria mellisii (BCC 1005)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.179

Comparison of sulforhodamine B, tetrazolium and clonogenic assays for in vitro radiosensitivity testing in human ovarian cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.179

Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.179

A comparison of clonogenic, microtetrazolium and sulforhodamine B assays for determination of cisplatin cytotoxicity in human ovarian carcinoma cell lines.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.179

Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.179

Antimony trichloride induces DNA damage and apoptosis in mammalian cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.179

Comparison of the sulforhodamine B assay and the clonogenic assay for in vitro chemoradiation studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.179

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NPROT.2006.179

1 reference

27 March 2018

PubMed ID

17406391

1 reference

27 March 2018